Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
6.55
+0.18 (2.83%)
At close: Jun 16, 2026, 4:00 PM EDT
6.50
-0.05 (-0.76%)
After-hours: Jun 16, 2026, 4:30 PM EDT

Relmada Therapeutics Statistics

Total Valuation

RLMD has a market cap or net worth of $687.03 million. The enterprise value is $447.82 million.

Market Cap687.03M
Enterprise Value 447.82M

Important Dates

The last earnings date was Tuesday, May 12, 2026, after market close.

Earnings Date May 12, 2026
Ex-Dividend Date n/a

Share Statistics

RLMD has 104.89 million shares outstanding. The number of shares has increased by 77.05% in one year.

Current Share Class 104.89M
Shares Outstanding 104.89M
Shares Change (YoY) +77.05%
Shares Change (QoQ) +41.74%
Owned by Insiders (%) 4.68%
Owned by Institutions (%) 61.79%
Float 75.72M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.05
P/TBV Ratio 3.12
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.26

Current Ratio 18.26
Quick Ratio 18.15
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -48.83% and return on invested capital (ROIC) is -29.77%.

Return on Equity (ROE) -48.83%
Return on Assets (ROA) -27.30%
Return on Invested Capital (ROIC) -29.77%
Return on Capital Employed (ROCE) -25.82%
Weighted Average Cost of Capital (WACC) 6.45%
Revenue Per Employee n/a
Profits Per Employee -$3.46M
Employee Count17
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +836.16% in the last 52 weeks. The beta is 0.40, so RLMD's price volatility has been lower than the market average.

Beta (5Y) 0.40
52-Week Price Change +836.16%
50-Day Moving Average 7.03
200-Day Moving Average 4.56
Relative Strength Index (RSI) 47.59
Average Volume (20 Days) 1,162,171

Short Selling Information

The latest short interest is 5.84 million, so 5.57% of the outstanding shares have been sold short.

Short Interest 5.84M
Short Previous Month 5.49M
Short % of Shares Out 5.57%
Short % of Float 7.71%
Short Ratio (days to cover) 6.27

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -57.44M
Pretax Income -58.88M
Net Income -58.88M
EBITDA n/a
EBIT -57.44M
Earnings Per Share (EPS) -$1.10
Full Income Statement

Balance Sheet

The company has $233.96 million in cash and n/a in debt, with a net cash position of $233.96 million or $2.23 per share.

Cash & Cash Equivalents 233.96M
Total Debt n/a
Net Cash 233.96M
Net Cash Per Share $2.23
Equity (Book Value) 218.73M
Book Value Per Share 2.09
Working Capital 222.45M
Full Balance Sheet

Cash Flow

Operating Cash Flow -42.79M
Capital Expenditures n/a
Depreciation & Amortization n/a
Net Borrowing n/a
Free Cash Flow -42.79M
FCF Per Share -$0.41
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RLMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -77.05%
Shareholder Yield -77.05%
Earnings Yield -8.64%
FCF Yield -6.28%

Analyst Forecast

The average price target for RLMD is $12.80, which is 95.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.80
Price Target Difference 95.42%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on September 30, 2019. It was a reverse split with a ratio of 1:4.

Last Split Date Sep 30, 2019
Split Type Reverse
Split Ratio 1:4

Scores

Altman Z-Score n/a
Piotroski F-Score 2